The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Mcdonald, Andrew Michael
    Individual (2 offsprings)
    Officer
    2025-04-02 ~ now
    OF - Secretary → CIF 0
  • 2
    Ellis, Benjamin James
    Company Director born in May 1971
    Individual (2 offsprings)
    Officer
    2025-04-02 ~ now
    OF - Director → CIF 0
  • 3
    Volle, Thierry Robert Andre
    President Of Emea born in July 1958
    Individual (2 offsprings)
    Officer
    2025-04-02 ~ now
    OF - Director → CIF 0
  • 4
    LUPIN (EUROPE) LIMITED - 2018-02-09
    LUPIN (UK) LIMITED - 2009-06-26
    The Urban Building Second Floor, 3-9 Albert Street, Slough, England
    Active Corporate (5 parents, 1 offspring)
    Person with significant control
    2025-04-02 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 4
  • 1
    Akhtar, Mobeen
    Director born in October 1981
    Individual (2 offsprings)
    Officer
    2015-02-04 ~ 2025-04-02
    OF - Director → CIF 0
    Mr Mobeen Akhtar
    Born in October 1981
    Individual (2 offsprings)
    Person with significant control
    2017-02-04 ~ 2025-04-02
    PE - Has significant influence or controlCIF 0
  • 2
    Mollison, Peter
    Director born in December 1980
    Individual (7 offsprings)
    Officer
    2015-02-04 ~ 2025-04-02
    OF - Director → CIF 0
    Mr Peter Mollison
    Born in December 1980
    Individual (7 offsprings)
    Person with significant control
    2017-02-04 ~ 2025-04-02
    PE - Has significant influence or controlCIF 0
  • 3
    Che, Ka Yan
    Director born in December 1980
    Individual (7 offsprings)
    Officer
    2015-02-04 ~ 2025-04-02
    OF - Director → CIF 0
    Mr Ka Yan Che
    Born in December 1980
    Individual (7 offsprings)
    Person with significant control
    2017-02-04 ~ 2025-04-02
    PE - Has significant influence or controlCIF 0
  • 4
    Patel, Haziq
    Director born in June 1974
    Individual (5 offsprings)
    Officer
    2015-02-04 ~ 2025-04-02
    OF - Director → CIF 0
    Mr Haziq Patel
    Born in June 1974
    Individual (5 offsprings)
    Person with significant control
    2017-02-04 ~ 2025-04-02
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

RENASCIENCE PHARMA LIMITED

Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Intangible Assets
1,531 GBP2024-02-29
3,063 GBP2023-02-28
Property, Plant & Equipment
4,913 GBP2024-02-29
6,750 GBP2023-02-28
Fixed Assets
6,444 GBP2024-02-29
9,813 GBP2023-02-28
Total Inventories
110,678 GBP2024-02-29
141,262 GBP2023-02-28
Debtors
120,003 GBP2024-02-29
13,396 GBP2023-02-28
Cash at bank and in hand
347,858 GBP2024-02-29
245,050 GBP2023-02-28
Current Assets
578,539 GBP2024-02-29
399,708 GBP2023-02-28
Net Current Assets/Liabilities
243,287 GBP2024-02-29
298,475 GBP2023-02-28
Total Assets Less Current Liabilities
249,731 GBP2024-02-29
308,288 GBP2023-02-28
Net Assets/Liabilities
248,798 GBP2024-02-29
308,288 GBP2023-02-28
Equity
Called up share capital
100 GBP2024-02-29
100 GBP2023-02-28
Retained earnings (accumulated losses)
248,698 GBP2024-02-29
308,188 GBP2023-02-28
Equity
248,798 GBP2024-02-29
308,288 GBP2023-02-28
Average Number of Employees
02023-03-01 ~ 2024-02-29
02022-03-01 ~ 2023-02-28
Intangible Assets - Gross Cost
Goodwill
15,314 GBP2024-02-29
15,314 GBP2023-02-28
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
13,783 GBP2024-02-29
12,251 GBP2023-02-28
Intangible Assets - Increase From Amortisation Charge for Year
Goodwill
1,532 GBP2023-03-01 ~ 2024-02-29
Intangible Assets
Goodwill
1,531 GBP2024-02-29
3,063 GBP2023-02-28
Property, Plant & Equipment - Gross Cost
Plant and equipment
29,899 GBP2024-02-29
27,848 GBP2023-02-28
Property, Plant & Equipment - Gross Cost
29,899 GBP2024-02-29
27,848 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
24,986 GBP2024-02-29
21,098 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
24,986 GBP2024-02-29
21,098 GBP2023-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
3,888 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment - Increase From Depreciation Charge for Year
3,888 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment
Plant and equipment
4,913 GBP2024-02-29
6,750 GBP2023-02-28
Trade Debtors/Trade Receivables
106,607 GBP2024-02-29
Other Debtors
13,396 GBP2024-02-29
13,396 GBP2023-02-28
Trade Creditors/Trade Payables
Amounts falling due within one year
73,640 GBP2024-02-29
Taxation/Social Security Payable
Amounts falling due within one year
254,071 GBP2024-02-29
95,065 GBP2023-02-28
Other Creditors
Amounts falling due within one year
7,541 GBP2024-02-29
6,168 GBP2023-02-28

  • RENASCIENCE PHARMA LIMITED
    Info
    Registered number 09420886
    The Urban Building Second Floor, 3-9 Albert Street, Slough, Berkshire SL1 2BE
    Private Limited Company incorporated on 2015-02-04 (10 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-04
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.